Compare OPRX & BGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPRX | BGX |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.1M | 135.2M |
| IPO Year | 2008 | 2010 |
| Metric | OPRX | BGX |
|---|---|---|
| Price | $6.38 | $10.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $16.67 | N/A |
| AVG Volume (30 Days) | ★ 301.7K | 61.9K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 124.55 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,429,000.00 | N/A |
| Revenue This Year | $3.88 | N/A |
| Revenue Next Year | $8.34 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 18.78 | N/A |
| 52 Week Low | $4.54 | $10.38 |
| 52 Week High | $22.25 | $12.65 |
| Indicator | OPRX | BGX |
|---|---|---|
| Relative Strength Index (RSI) | 56.91 | 32.60 |
| Support Level | $6.03 | $10.58 |
| Resistance Level | $6.93 | $10.93 |
| Average True Range (ATR) | 0.24 | 0.06 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 48.47 | 8.64 |
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. The company's seeks to achieve its investment objectives by employing a dynamic long-short strategies in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.